6-Bromo-2-oxo-1,2-dihydroquinoline-3-carboxylic acid, 97%, 1g

8-(2,2,2-trifluoroethyl)-7H-purin-6-amine, 97%, 100mg

1-(2,4-Difluorophenyl)-2-(1H-1,2,4-triazol-1-yl)ethanone, 99.00%, 500g

3,5-Dichlorobenzohydrazide, 97.0%, 1g

Tetrahydrothiopyran-4-carbonitrile, 97.0%, 1g

(2E)-1-(3,4-dichlorophenyl)-3-(thiophen-2-yl)prop-2-en-1-one, 95.0%, 10g

5-BROMO-4-CHLORO-2-(2,5-DIMETHYL-1H-PYRROL-1-YL)-6-METHYLPYRIMIDINE, 95.0%, 250mg

Azelnidipine>98.0%(HPLC)(T)5g

Ethyl 4-piperidone-N-carboxylate, 98.0%, 100g

2-(3-Methyl-2,6-dioxo-1,2,3,6-tetrahydro-7h-purin-7-yl)acetic acid, 97%, 100mg

4-Vinylbenzonitrile, 97%, 1g

tert-Butyl 7-oxo-2-azaspiro[3.5]nonane-2-carboxylate, 95.0%, 5g

Volumetric flasks DURAN® class A, USP<31>, 200 ml, 14/23, 2 Piece(s)